# EDGAR Filing Document

**Accession Number:** 0001529113
**File Stem:** 0001213900-23-024634
**Filing Date:** 2023-3
**Character Count:** 36273
**Document Hash:** a68588bec401ef8c9415ab9c8d322c57
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-024634.hdr.sgml**: 20230330

**ACCESSION NUMBER**: 0001213900-23-024634

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230330

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230330

**DATE AS OF CHANGE**: 20230330

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INPIXON
- **CENTRAL INDEX KEY:** 0001529113
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **IRS NUMBER:** 880434915
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36404
- **FILM NUMBER:** 23780778

**BUSINESS ADDRESS:**
- **STREET 1:** 2479 E. BAYSHORE ROAD
- **STREET 2:** SUITE 195
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94303
- **BUSINESS PHONE:** (408) 702-2167

**MAIL ADDRESS:**
- **STREET 1:** 2479 E. BAYSHORE ROAD
- **STREET 2:** SUITE 195
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94303

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sysorex Global
- **DATE OF NAME CHANGE:** 20160216

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sysorex Global Holdings Corp.
- **DATE OF NAME CHANGE:** 20130808

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sysorex Global Holding Corp.
- **DATE OF NAME CHANGE:** 20110901

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): March 30, 2023**

**INPIXON**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Nevada** | **001-36404** | **88-0434915** |
| (State or other jurisdiction<br> of incorporation) | (Commission File Number) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **2479 E. Bayshore Road, Suite 195**<br> **Palo Alto, CA** | **94303** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(408) 702-2167**

**N/A**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol(s)** | **Name of Each Exchange on Which Registered** |
| Common Stock | INPX | The Nasdaq Stock Market LLC |

---

**Item 2.02** **Results of Operations and Financial Condition.**

On March 30, 2023, Inpixon issued a press release and will hold a conference call regarding its financial results for the year ended December 31, 2022. The press release is included as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein, and the description of the press release is qualified in its entirety by reference to such Exhibit.

The information furnished with this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Inpixon is making reference to non-GAAP financial information in both the press release and the conference call. A reconciliation of GAAP to non-GAAP results is provided in the attached Exhibit 99.1 press release.

**Item 9.01** **Financial Statements and Exhibits.**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | [Press Release dated March 30, 2023.](ea176093ex99-1_inpixon.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **INPIXON** | **INPIXON** |
| Date: March 30, 2023 | By: | /s/ Nadir Ali |
|  | Name: | Nadir Ali |
|  | Title: | Chief Executive Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

**News Release**

**Inpixon Reports 2022 Financial Results and Provides Business Update**

Inpixon Reports 21% Growth in Revenue to $19.4 Million for the 2022 Fiscal Year

 

*Conference Call to be Held Today at 4:30 p.m. Eastern Time* 

PALO ALTO, Calif., March 30, 2023 /PRNewswire/ -- Inpixon<sup>®</sup> (Nasdaq: INPX), the Indoor Intelligence<sup>®</sup> company, today provided a business update and reported financial results for the fiscal year ended December 31, 2022.

"We completed 2022 with a 21% increase in revenue. We also implemented initiatives to reduce our operating expenses and overhead costs and remain actively committed to pursuing meaningful opportunities that will provide our shareholders with additional value," commented Nadir Ali, CEO of Inpixon. "The recently completed spin-off of our workplace experience products and business, which was a primary focus of the company during the second half of 2022, will allow Inpixon shareholders that were eligible to participate in the distribution to share in the potential upside of an investment in two separate and independent public companies. We believe this transaction was a significant accomplishment structured for the benefit of our shareholders. To the same end, we are also actively pursuing other opportunities for the remainder of our business that we believe will increase total enterprise value. Inpixon also continues to be recognized as an industry leading provider for indoor location services. For the fifth consecutive year, Inpixon has been recognized in the Gartner<sup>®</sup> Magic Quadrant™ for Indoor Location Services report<sup>1</sup>, with this year marking the second consecutive year being named a *Leader* in the industry. Moving forward into 2023, we will continue to focus on accelerating the growth of our real-time location system (RTLS) business and further penetrating the market which is projected to reach $12.7 billion by 2026, a CAGR of 26.5%, according to research firm MarketsandMarkets.

"Over the years, we have developed expertise in advanced technologies which allows us to support the digital transformation underway in many industries. Our full-stack industrial RTLS allows customers to locate, learn, and leverage business and operational intelligence to reduce costs, grow revenue, and increase productivity. This is done by creating a connected, visible, and automated industrial workflow with our industrial IoT (IIoT) platform, location-aware sensors, digital twins and advanced applications, which are scalable, flexible, and intelligent. Given our ability to address a wide variety of important use cases, we have secured new customers and numerous purchase orders during the year. We believe the breath of our software and hardware products that make up our RTLS solution sets us apart from others in the market. We believe we are at the forefront of this industry and well positioned to take advantage of the vast opportunities. We look forward to achieving additional milestones in 2023 for our RTLS business."

**B** **usiness Highlights**

● Completed distribution of workplace experience app business and business combination with CXApp Inc. (formerly KINS Technology Group Inc.) .

● Named Leader in 2023 Gartner<sup>®</sup> Magic Quadrant™ for Indoor Location Services.

● Secured a purchase order valued at over $1 million for Inpixon's RTLS products from a leading transportation and industrial equipment provider.

● Announced a collaboration agreement with Schauenburg Systems, an original-equipment manufacturer of mine safety systems and equipment, to sell Inpixon's real-time location technologies.

● Achieved FCC, ISED Certifications and established CE status for Inpixon Swarm Chirp V3.

● Joined SAP<sup>®</sup> Partner Program, offering location intelligence for advanced RTLS-enabled industrial automation.

1 Gartner Magic Quadrant for Indoor Location Services, Tim Zimmerman, Annette Zimmermann, February 21, 2023.

inpixon.com 1

**Financial Results**

Revenues for the year ended December 31, 2022 were $19.4 million compared to $16.0 million for the comparable period in the prior year for an increase of approximately $3.4 million, or approximately 21%. This increase is primarily attributable to an increase in Indoor Intelligence sales, including $2.6 million from smart office app sales and $0.9 million from real time location-based technologies. Gross profit for the year ended December 31, 2022, was $13.9 million compared to a gross profit of $11.6 million for the 2021 fiscal year, representing an increase of 20%. The gross profit margin for the year ended December 31, 2022 was 72% compared to 73% for the year ended December 31, 2021. This lower margin is primarily due to the sales mix during the year. Net loss attributable to stockholders for the year ended December 31, 2022 was $63.4 million compared to $69.2 million for the comparable period in the prior year. This decrease in loss of approximately $5.8 million was primarily attributable to the decrease in operating expenses of $13.7 million and the higher gross margin of $2.3 million offset by an increase in other loss of $10.9 million.

Non-GAAP Adjusted EBITDA for the year ended December 31, 2022 was a loss of $26.6 million compared to a loss of $29.6 million for the prior year period. Non-GAAP Adjusted EBITDA is defined as net income or loss before interest, provision for income taxes, depreciation, and amortization plus adjustments for other income or expense items, non-recurring items and non-cash items including stock-based compensation.

Proforma non-GAAP net loss per basic and diluted common share for the year ended December 31, 2022 was $12.25 compared to a loss of $18.77 per share for the prior year period. Non-GAAP net loss per share is defined as net loss per basic and diluted share adjusted for non-cash items including stock-based compensation, amortization of intangibles and one-time charges and other adjustments including impairment of goodwill and intangibles, provision for valuation allowance on notes, and acquisition costs.

 

*These financial results for 2022 are based on information available to management as of the date of this press release, and may be subject to further changes upon completion of the Company's quarterly and year-end operational and financial closing procedures.*

**Conference Call**

Inpixon management will host a conference call today at 4:30 p.m. Eastern Time to discuss the company's financial results for the fiscal year ended December 31, 2022, as well as to review the company's corporate progress and other developments.

The conference call will be available via telephone by dialing toll-free 888-506-0062 for U.S. callers or 973-528-0011 for international callers and entering access code 246549. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2235/47912 or on the company's Investor Relations section of the website, ir.inpixon.com.

Investors and other interested parties are invited to submit questions to management prior to the call's start via email to inpx@crescendo-ir.com.

A webcast replay will be available on the company's Investor Relations section of the website (ir.inpixon.com) through March 30, 2024. A telephone replay of the call will be available approximately one hour following the call, through April 6, 2023, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and entering access code 47912.

**Gartner Disclaimer**

Gartner and Magic Quadrant are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of the Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

inpixon.com 2

**About Inpixon**

Inpixon<sup>®</sup> (Nasdaq: INPX) is the innovator of Indoor Intelligence<sup>®</sup>, delivering actionable insights for people, places and things. Combining the power of mapping, positioning and analytics, Inpixon helps to create smarter, safer, and more secure environments. The company's Indoor Intelligence and industrial real-time location system (RTLS) solutions are leveraged by a multitude of industries to optimize operations, increase productivity, and enhance safety. Inpixon customers can take advantage of industry leading location awareness, analytics, sensor fusion, IIoT and the IoT to create exceptional experiences and to do good with indoor data. For the latest insights, follow Inpixon on LinkedIn, and Twitter, and visit inpixon.com.

**Safe Harbor Statement**

 

*All statements in this release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of the control of Inpixon and its subsidiaries, which could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the fluctuation of economic conditions, the impact of COVID-19, global conflicts, inflation and other global events on Inpixon's results of operations and global supply chain constraints, Inpixon's ability to integrate the products and business from acquisitions into its existing business, the performance of management and employees, the regulatory landscape as it relates to privacy regulations and their applicability to Inpixon's technology, Inpixon's ability to maintain compliance with Nasdaq's continued listing requirements, the ability to obtain financing if needed, competition, general economic conditions and other factors that are detailed in Inpixon's periodic and current reports available for review at sec.gov. Furthermore, Inpixon operates in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. Inpixon disclaims any intention to, and undertakes no obligation to, update or revise forward-looking statements.*

**Non-GAAP Financial Measures**

Management believes that certain financial measures not in accordance with generally accepted accounting principles in the United States ("GAAP") are useful measures of operations. EBIDTA, Adjusted EBITDA and pro forma net loss per share are non-GAAP measures. Inpixon defines "EBITDA" as net income (loss) before interest, provision for (benefit from) income taxes, and depreciation and amortization. Management uses Adjusted EBITDA as a metric for which it manages the business, and Inpixon defines "Adjusted EBITDA" as EBITDA plus adjustments for other income or expense items, non-recurring items and non-cash items. Inpixon defines "pro forma net loss per share" as GAAP net loss per share adjusted for stock-based compensation, amortization of intangibles and one-time charges including loss on the exchange of debt for equity and provision for valuation allowances.

Management provides Adjusted EBITDA and pro forma net loss per share measures so that investors will have the same financial information that management uses, which may assist investors in assessing Inpixon's performance on a period-over-period basis. Adjusted EBITDA or pro forma net loss per share is not a measure of financial performance under GAAP, and should not be considered an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA and pro forma net loss per share have limitations as analytical tools and should not be considered either in isolation or as a substitute for analysis of Inpixon's results as reported under GAAP.

For more information on our non-GAAP financial measures and a reconciliation of GAAP to non-GAAP measures, please see the "Reconciliation of Non-GAAP Financial Measures" table accompanying this press release.

**Contacts**

**General inquiries:**<br> Inpixon<br> Email: marketing@inpixon.com<br> Web: inpixon.com/contact-us

**Investor relations:**<br> Crescendo Communications for Inpixon<br> Tel: +1 212-671-1020<br> Email: INPX@crescendo-ir.com

inpixon.com 3

**INPIXON AND SUBSIDIARIES**

**CONSOLIDATED BALANCE SHEETS**

**(In thousands, except number of shares and par value data)**

---

| | | |
|:---|:---|:---|
|  | **As of** | **As of** |
|  | **December 31,<br> 2022** | **December 31,<br> 2021** |
| **ASSETS** | | |
| **Current Assets** | | |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $20235 | $52480 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net of allowances of $231 and $272, respectively | 3227 | 3218 |
| &nbsp;&nbsp;&nbsp;Other receivables | 359 | 321 |
| &nbsp;&nbsp;&nbsp;Inventory, net | 2442 | 1976 |
| &nbsp;&nbsp;&nbsp;Short-term investments |  | 43125 |
| &nbsp;&nbsp;&nbsp;Note receivable | 150 |  |
| &nbsp;&nbsp;&nbsp;Prepaid assets and other current assets | 3453 | 4842 |
| **Total Current Assets** | 29866 | 105962 |
| Property and equipment, net | 1266 | 1442 |
| Operating lease right-of-use asset, net | 1212 | 1736 |
| Software development costs, net | 1752 | 1792 |
| Investment in equity securities | 330 | 1838 |
| Long-term investments | 716 | 2500 |
| Intangible assets, net | 22283 | 33478 |
| Goodwill,net |  | 7672 |
| Other assets | 210 | 253 |
| **Total Assets** | $57635 | $156673 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| **Current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $2557 | $2414 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities | 4355 | 10665 |
| &nbsp;&nbsp;&nbsp;Operating lease obligation, current | 477 | 643 |
| &nbsp;&nbsp;&nbsp;Deferred revenue | 3485 | 4805 |
| &nbsp;&nbsp;&nbsp;Short-term debt | 13643 | 3490 |
| &nbsp;&nbsp;&nbsp;Acquisition liability | 197 | 5114 |
| **Total Current Liabilities** | 24714 | 27131 |
| **Long Term Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Operating lease obligations, noncurrent | 778 | 1108 |
| &nbsp;&nbsp;&nbsp;Other liabilities, noncurrent | 28 | 28 |
| &nbsp;&nbsp;&nbsp;Acquisition liability, noncurrent | -- | 220 |
| **Total Liabilities** | 25520 | 28487 |
| **Commitments and Contingencies** |  |  |
| **Mezzanine Equity** |  |  |
| &nbsp;&nbsp;&nbsp;Series 7 Convertible Preferred Stock - 58,750 shares authorized; zero and 49,250 issued and outstanding as of December 31, 2022 and December 31, 2021, respectively. |  | 44695 |
| &nbsp;&nbsp;&nbsp;Series 8 Convertible Preferred Stock - 53,197.7234 shares authorized; zero issued and outstanding as of December 31, 2022 and December 31, 2021, respectively. |  |  |
| **Stockholders' Equity** |  |  |
| &nbsp;&nbsp;&nbsp;Preferred Stock - $0.001 par value; 5,000,000 shares authorized. |  |  |
| &nbsp;&nbsp;&nbsp;Series 4 Convertible Preferred Stock - 10,415 shares authorized; 1 issued, and 1 outstanding as of December 31, 2022 and December 31, 2021, respectively; |  |  |
| &nbsp;&nbsp;&nbsp;Series 5 Convertible Preferred Stock - 12,000 shares authorized; 126 issued, and 126 outstanding as of December 31, 2022 and December 31, 2021, respectively. |  |  |
| &nbsp;&nbsp;&nbsp;Common Stock - $0.001 par value; 500,000,000 shares authorized; 3,570,894 and 1,730,141 issued and 3,570,893 and 1,730,140 outstanding as of December 31, 2022 and December 31, 2021, respectively. | 4 | 2 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 346668 | 332761 |
| &nbsp;&nbsp;&nbsp;Treasury stock, at cost, 1 share | (695) | (695) |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 1061 | 44 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (314841) | (250309) |
| &nbsp;&nbsp;&nbsp;Stockholders' Equity Attributable to Inpixon | 32197 | 81803 |
| &nbsp;&nbsp;&nbsp;Non-controlling interest | (82) | 1688 |
| **Total Stockholders' Equity** | 32115 | 83491 |
| **Total Liabilities, Mezzanine Equity and Stockholders' Equity** | $57635 | $156673 |

---

inpixon.com 4

**INPIXON AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS**

**(In thousands, except per share data)**

---

| | | |
|:---|:---|:---|
|  | **For the Years Ended** | **For the Years Ended** |
|  | **December 31,** | **December 31,** |
|  | **2022** | **2021** |
| **Revenues** | $19418 | $15995 |
| **Cost of Revenues** | 5489 | 4374 |
| **Gross Profit** | 13929 | 11621 |
| **Operating Expenses** |  |  |
| &nbsp;&nbsp;&nbsp;Research and development | 17661 | 14121 |
| &nbsp;&nbsp;&nbsp;Sales and marketing | 8872 | 8261 |
| &nbsp;&nbsp;&nbsp;General and administrative | 26060 | 41478 |
| &nbsp;&nbsp;&nbsp;Acquisition related costs | 426 | 1248 |
| &nbsp;&nbsp;&nbsp;Impairment of goodwill and intangibles | 12199 | 14789 |
| &nbsp;&nbsp;&nbsp;Amortization of intangibles | 5411 | 4467 |
| **Total Operating Expenses** | 70629 | 84364 |
| **Loss from Operations** | (56700) | (72743) |
| **Other Income (Expense)** |  |  |
| &nbsp;&nbsp;&nbsp;Interest (expense)/ income, net | (673) | 1183 |
| &nbsp;&nbsp;&nbsp;Loss on exchange of debt for equity |  | (30) |
| &nbsp;&nbsp;&nbsp;Benefit for valuation allowance on related party loan - held for sale |  | 7345 |
| &nbsp;&nbsp;&nbsp;Other income/(expense) | 692 | (47) |
| &nbsp;&nbsp;&nbsp;Gain on related party loan - held for sale |  | 49817 |
| &nbsp;&nbsp;&nbsp;Unrealized loss on equity securities | (7904) | (57067) |
| &nbsp;&nbsp;&nbsp;Unrealized loss on equity method investment | (1784) | -- |
| **Total Other Income (Expense)** | (9669) | 1201 |
| **Net Loss, before tax** | (66369) | (71542) |
| &nbsp;&nbsp;&nbsp;Income tax benefit | 65 | 1412 |
| **Net Loss** | (66304) | (70130) |
| **Net Loss Attributable to Non-controlling Interest** | (2910) | (975) |
| **Net Loss Attributable to Stockholders of Inpixon** | $(63394) | $(69155) |
| Accretion of Series 7 preferred stock | (4555) | (8161) |
| Accretion of Series 8 Preferred Stock | (13090) |  |
| Deemed dividend for the modification related to Series 8 Preferred Stock | (2627) |  |
| Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock | 1469 |  |
| Amortization premium- modification related to Series 8 Prefered Stock | 2627 | -- |
| **Net Loss Attributable to Common Stockholders** | $(79570) | $(77316) |
| **Net Loss Per Share - Basic and Diluted** | $(34.12) | $(51.18) |
| **Weighted Average Shares Outstanding** |  |  |
| &nbsp;&nbsp;&nbsp;Basic and Diluted | 2332041 | 1510678 |
| **Comprehensive Loss** |  |  |
| Net Loss | $(66304) | $(70130) |
| Unrealized foreign exchange gain (loss) from cumulative translation adjustments | 1017 | (617) |
| **Comprehensive Loss** | $(65287) | $(70747) |

---

inpixon.com 5

**INPIXON AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(In thousands)**

---

| | | |
|:---|:---|:---|
|  | **For the Years Ended** | **For the Years Ended** |
|  | **December 31,** | **December 31,** |
|  | **2022** | **2021** |
| **Cash Flows Used In Operating Activities** |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(66304) | $(70130) |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 1374 | 1344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 6082 | 5107 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of right of use asset | 706 | 677 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock options and restricted stock awards granted to employees and consultants for services | 3656 | 10879 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnout payment expense | (2827) | 6524 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on exchange of debt for equity |  | 30 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discount | 489 | 224 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued interest income, related party | (278) | (1627) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for doubtful accounts | (32) | 121 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized gain/(loss) on note | 1707 | (92) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for inventory obsolescense | 10 | 300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recovery for valuation allowance held for sale loan |  | (7345) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on settlement of related party promissory note |  | (49817) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax | (1) | (2593) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss on equity securities | 7904 | 57067 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of goodwill and intangibles | 12199 | 14789 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal of property and equipment | 1 | 24 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Realized gain on sale of equity securities | 151 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss on equity method investment | 1784 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on conversion of note receivable | (791) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 211 | 235 |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable and other receivables | (115) | (313) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory | (565) | (112) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 1375 | (4006) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 33 | 199 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 182 | 391 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 858 | 490 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax liabilities | 119 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | (1214) | 817 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligation | (677) | (658) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | -- | 328 |
| **Net Cash Used in Operating Activities** | $(33963) | $(37131) |
| **Cash Flows Used in Investing Activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of property and equipment | (245) | (346) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment in capitalized software | (948) | (1019) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of short term investments |  | (2000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales of short term investments |  | 2000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of treasury bills |  | (63362) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales of treasury bills | 43001 | 28000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales of equity securities | 229 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of convertible note | (5500) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of note receivable | (150) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment in Systat licensing agreement |  | (900) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of intangible assets |  | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition of Intranav |  | (1023) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition of Game Your Game |  | 184 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition of CXApp |  | (14977) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition of Visualix | -- | (61) |
| **Net Cash Provided by (Used in) Investing Activities** | $36387 | $(53508) |
| **Cash From Financing Activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from issuance of preferred stock and warrants | $46906 | $50585 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from issuance of common stock and warrants |  | 77852 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from promissory note | 12339 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Taxes paid related to net share settlement of restricted stock units | (336) | (1855) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loans to related party |  | (117) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds for registered direct offering | 14088 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common shares issued for net proceeds from warrants | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for redemption of preferred stock series 7 | (49250) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for redemption of preferred stock series 8 | (53198) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of CXApp acquisition liability | (5136) | (461) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of acquisition liability to Nanotron shareholders |  | (467) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of acquisition liability to Locality shareholders | -- | (500) |
| **Net Cash (Used in) Provided By Financing Activities** | $(34586) | $125037 |
| **Effect of Foreign Exchange Rate on Changes on Cash** | (83) | 86 |
| **Net (Decrease) Increase in Cash and Cash Equivalents** | (32245) | 34484 |
| Cash and Cash Equivalents - Beginning of year | 52480 | 17996 |
| Cash and Cash Equivalents - End of year | $20235 | $52480 |

---

inpixon.com 6

**Reconciliation of Non-GAAP Financial Measures:**

---

| | | |
|:---|:---|:---|
| | **For the Years Ended<br> December 31,** | **For the Years Ended<br> December 31,** |
| <br>**(In thousands)** | **2022** | **2021** |
| Net loss attributable to common stockholders | $(79570) | $(77316) |
| &nbsp;&nbsp;&nbsp;Interest expense/(income), net | 673 | (1183) |
| &nbsp;&nbsp;&nbsp;Income tax benefit | (65) | (1412) |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 7456 | 6451 |
| EBITDA | (71506) | (73460) |
| *Adjusted for:* |  |  |
| &nbsp;&nbsp;&nbsp;Non-recurring one-time charges: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on exchange of debt for equity |  | 30 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recovery for valuation allowance on held for sale loan |  | (7345) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on related party loan held for sale |  | (49817) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss on equity securities | 7904 | 57067 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss on equity method investment | 1784 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition transaction/financing costs | 426 | 1248 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnout compensation expense |  | 6524 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Professional service fees | 8 | 1366 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accretion of series 7 preferred stock | 4555 | 8161 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accretion of series 8 preferred stock | 13090 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deemed dividend modification Series 8 preferred stock | 2627 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deemed contribution modification of warrants | (1469) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization premium modification of Series 8 preferred stock | (2627) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of goodwill and intangible assets | 12199 | 14789 |
| &nbsp;&nbsp;&nbsp;Unrealized gains on notes and loans | 1707 | 241 |
| &nbsp;&nbsp;&nbsp;Bad debts expense/provision | (31) | 121 |
| &nbsp;&nbsp;&nbsp;Reserve for inventory obsolescence | 1 | 300 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation – compensation and related benefits | 3656 | 10879 |
| &nbsp;&nbsp;&nbsp;Severance costs | 250 | 294 |
| &nbsp;&nbsp;&nbsp;Restructuring Costs | 845 | - |
| Adjusted EBITDA | $(26581) | $(29602) |

---

inpixon.com 7

---

| | | |
|:---|:---|:---|
| | **For the Years Ended<br> December 31,** | **For the Years Ended<br> December 31,** |
| <br>**(In thousands, except share data)** | **2022** | **2021** |
| Net loss attributable to common stockholders | $(79570) | $(77316) |
| Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;Non-recurring one-time charges: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on exchange of debt for equity |  | 30 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recovery for valuation allowance on held for sale loan |  | (7345) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on related party loan held for sale |  | (49817) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss on equity securities | 7904 | 57067 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized loss on equity method investment | 1784 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition transaction/financing costs | 426 | 1248 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnout compensation expense |  | 6524 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Professional service fees | 8 | 1366 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accretion of series 7 preferred stock | 4555 | 8161 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accretion of series 8 preferred stock | 13090 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deemed dividend modification Series 8 preferred stock | 2627 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deemed contribution modification of warrants | (1469) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization premium modification of Series 8 preferred stock | (2627) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of goodwill and intangible assets | 12199 | 14789 |
| &nbsp;&nbsp;&nbsp;Unrealized gains on notes and loans | 1707 | 241 |
| &nbsp;&nbsp;&nbsp;Bad debts expense/provision | (31) | 121 |
| &nbsp;&nbsp;&nbsp;Reserve for inventory obsolescence | 1 | 300 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation – compensation and related benefits | 3656 | 10879 |
| &nbsp;&nbsp;&nbsp;Severance costs | 250 | 294 |
| &nbsp;&nbsp;&nbsp;Restructuring costs | 845 |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangibles | 6082 | 5107 |
| Proforma non-GAAP net loss | $(28563) | $(28351) |
| Proforma non-GAAP net loss per basic and diluted common share | $(12.25) | $(18.77) |
| Weighted average basic and diluted common shares outstanding | 2332041 | 1510678 |

---

inpixon.com 8